We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Mulls Program to Let Drugmakers Reserve Proprietary Name
FDA Mulls Program to Let Drugmakers Reserve Proprietary Name
The FDA is considering letting branded drugmakers reserve a proprietary name for a new product, with the goal of avoiding potential delays by approving permanent drug names well in advance of product launch.